Boston Partners Acquires 393,600 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Boston Partners grew its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 25.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,956,353 shares of the company's stock after buying an additional 393,600 shares during the period. Boston Partners owned 2.28% of Pediatrix Medical Group worth $25,922,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Quest Partners LLC raised its holdings in Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after acquiring an additional 622 shares during the period. Parkside Financial Bank & Trust increased its stake in shares of Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares during the period. Quarry LP increased its stake in shares of Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after purchasing an additional 1,662 shares during the period. AlphaQuest LLC lifted its holdings in Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its stake in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after purchasing an additional 6,090 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Pediatrix Medical Group Price Performance

MD traded up $0.30 on Monday, hitting $14.51. 593,809 shares of the stock were exchanged, compared to its average volume of 811,255. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of -12.09, a PEG ratio of 1.74 and a beta of 1.49. The business has a 50-day moving average of $14.31 and a two-hundred day moving average of $13.55.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on MD shares. UBS Group increased their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research report on Friday, February 21st. Truist Financial raised their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research report on Friday, February 21st. StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Finally, Macquarie assumed coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an "outperform" rating and a $18.00 target price on the stock. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.